Nice sales for a few days work!
Biolase Technology, Inc. Reports Record Sales at the Chicago Dental Society Mid Winter Meeting
Thursday, February 25, 1999 08:32 AM Mail this article to a friend new!
SAN CLEMENTE, Calif., Feb. 25 /PRNewswire/ -- BIOLASE TECHNOLOGY, INC. (Nasdaq: BLTI) The strong sales at the Mid Winter meeting of the Chicago Dental Society set a new record for Millennium sales orders. Millennium Hydrokinetic YSGG sales orders at the Chicago meeting exceeded $600,000. All of these orders were finalized with deposits or signed lease agreements. Biolase also expects to realize numerous additional orders from this meeting. Historically, dentists attending this meeting have been very conservative and in the past were reluctant to finalize purchases of high technology and lasers. "We believe that the confidence demonstrated by dentists purchasing the Millennium confirms the superior clinical and economic benefits of Biolase's YSGG technology," stated Jeffrey W. Jones, President and CEO of Biolase.
According to Biolase Vice President of Global Sales, Keith G. Bateman, "While some analysts projected that Biolase would sell a few Millennium systems at the Chicago meeting, our team planned and executed marketing, promotional and demonstration strategies to exceed those expectations." Bateman continued, "Our experienced sales force, which we are currently expanding, was well prepared to educate the dentists about the clinical and economic advantages of incorporating Hydrokinetic technology into their practices. They clearly demonstrated to the dentists that the Millennium can make their practices more profitable and effectively cuts enamel, dentin, caries and also does soft tissue surgical procedures without anesthesia and pain in most cases."
BIOLASE Technology, Inc. (www.biolase.com) manufactures and markets advanced dental, cosmetic, aesthetic, and surgical products, including the LazerSmile tooth whitening system (www.lazersmile.com), Hydrokinetic(TM) surgical cutting systems, and other advanced laser and non-laser based products for the professional and home consumer market. The company's products incorporate patented and patent-pending technologies in the pursuit of painless surgery.
The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time-to-time in the Company's filings with the Securities and Exchange Commission, including the reports on Forms 10-K and 10-Q. These forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims, however, any intent or obligation to update these forward-looking statements.
SOURCE Biolase Technology, Inc.
CONTACT: Scott Liolios of Pacific Consulting Group, Inc., 949-574-3860; or Jeffrey W. Jones of BIOLASE Technology, Inc., 949-361-1200
Quote for referenced ticker symbols: BLTI
© 1999, PR Newswire
|
